REMD BIOTHERAPEUTICS, INC.

Organization

CAMARILLO, CA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Calcitonin gene-related peptide (CGRP) antagonist antibodies
- Patent number 11,629,184
- Issue date Apr 18, 2023
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for treating heart failure using glucagon receptor antagoni...
- Patent number 11,446,376
- Issue date Sep 20, 2022
- REMD Biotherapeutics, Inc.
- Hai Yan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating type 1 diabetes using glucagon receptor antago...
- Patent number 11,447,555
- Issue date Sep 20, 2022
- REMD Biotherapeutics, Inc.
- Hai Yan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunotherapy using antibodies that bind programmed death ligand-1...
- Patent number 11,332,531
- Issue date May 17, 2022
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination of glucagon receptor antagonists and PI3K pathway inhib...
- Patent number 11,319,376
- Issue date May 3, 2022
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cancer treatment using antibodies that bind cytotoxic T-lymphocyte...
- Patent number 11,319,372
- Issue date May 3, 2022
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunotherapy using antibodies that bind Programmed Death 1 (PD-1)
- Patent number 11,248,049
- Issue date Feb 15, 2022
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-OX40 antibodies and methods of activating OX40
- Patent number 11,242,398
- Issue date Feb 8, 2022
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for treating heart failure using glucagon receptor antagoni...
- Patent number 10,765,737
- Issue date Sep 8, 2020
- REMD Biotherapeutics, Inc.
- Hai Yan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating obesity and nonalcoholic fatty liver disease o...
- Patent number 10,752,693
- Issue date Aug 25, 2020
- REMD Biotherapeutics, Inc.
- Hai Yan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating type 1 diabetes using glucagon receptor antago...
- Patent number 10,626,179
- Issue date Apr 21, 2020
- REMD Biotherapeutics, Inc.
- Hai Yan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
HUMAN ENDOTHELIN RECEPTOR A (ETAR) ANTAGONIST ANTIBODIES
- Publication number 20230212300
- Publication date Jul 6, 2023
- REMD Biotherapeutics, Inc.
- Hai Yan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHEMOKINE RECEPTOR 4 (CXCR4) ANTAGONIST ANTIBODIES
- Publication number 20230151104
- Publication date May 18, 2023
- REMD Biotherapeutics, Inc.
- Hai Yan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Methods Of Treating Type 2 Diabetes Mellitus Using Glucagon Recepto...
- Publication number 20220112294
- Publication date Apr 14, 2022
- REMD Biotherapeutics, Inc.
- Jim Shi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS USING ANTIBODIES...
- Publication number 20210079087
- Publication date Mar 18, 2021
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CANCER TREATMENT USING ANTIBODIES THAT BIND HUMAN CD134 (OX40) RECE...
- Publication number 20210024640
- Publication date Jan 28, 2021
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CALCITONIN GENE-RELATED PEPTIDE (CGRP) ANTAGONIST ANTIBODIES
- Publication number 20200407433
- Publication date Dec 31, 2020
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR TREATING HEART FAILURE USING GLUCAGON RECEPTOR ANTAGONI...
- Publication number 20200353079
- Publication date Nov 12, 2020
- REMD Biotherapeutics, Inc.
- Hai Yan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods For Treating Obesity And Nonalcoholic Fatty Liver Disease O...
- Publication number 20200339697
- Publication date Oct 29, 2020
- REMD Biotherapeutics, Inc.
- Hai Yan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods For Treating Type 1 Diabetes Using Glucagon Receptor Antago...
- Publication number 20200239582
- Publication date Jul 30, 2020
- REMD Biotherapeutics, Inc.
- Hai Yan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOTHERAPY USING ANTIBODIES THAT BIND PROGRAMMED DEATH LIGAND-1...
- Publication number 20200190197
- Publication date Jun 18, 2020
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CANCER TREATMENT USING ANTIBODIES THAT BIND CYTOTOXIC T-LYMPHOCYTE...
- Publication number 20200055937
- Publication date Feb 20, 2020
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNOTHERAPY USING ANTIBODIES THAT BIND PROGRAMMED DEATH 1 (PD-1)
- Publication number 20190330346
- Publication date Oct 31, 2019
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION OF GLUCAGON RECEPTOR ANTAGONISTS AND PI3K PATHWAY INHIB...
- Publication number 20190169300
- Publication date Jun 6, 2019
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods For Treating Rare Genetic Disorders Using Glucagon Receptor...
- Publication number 20190062441
- Publication date Feb 28, 2019
- REMD Biotherapeutics, Inc.
- Hai Yan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods Of Treating Type 2 Diabetes Mellitus Using Glucagon Recepto...
- Publication number 20190002577
- Publication date Jan 3, 2019
- REMD Biotherapeutics, Inc.
- Jim Shi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING HEART FAILURE USING GLUCAGON RECEPTOR ANTAGONI...
- Publication number 20180256713
- Publication date Sep 13, 2018
- REMD Biotherapeutics, Inc.
- Hai Yan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods For Treating Obesity And Nonalcoholic Fatty Liver Disease O...
- Publication number 20180079820
- Publication date Mar 22, 2018
- REMD Biotherapeutics, Inc.
- Hai Yan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods For Treating Type 1 Diabetes Using Glucagon Receptor Antago...
- Publication number 20170240641
- Publication date Aug 24, 2017
- REMD Biotherapeutics, Inc.
- Hai Yan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods For Treating Heart Failure Using Glucagon Receptor Antagonists
- Publication number 20170143673
- Publication date May 25, 2017
- REMD Biotherapeutics, Inc.
- Hai Yan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

REMD BIOTHERAPEUTICS, INC.

Organization

Patents Grantslast 30 patents

Calcitonin gene-related peptide (CGRP) antagonist antibodies

Methods for treating heart failure using glucagon receptor antagoni...

Methods for treating type 1 diabetes using glucagon receptor antago...

Immunotherapy using antibodies that bind programmed death ligand-1...

Combination of glucagon receptor antagonists and PI3K pathway inhib...

Cancer treatment using antibodies that bind cytotoxic T-lymphocyte...

Immunotherapy using antibodies that bind Programmed Death 1 (PD-1)

Anti-OX40 antibodies and methods of activating OX40

Methods for treating heart failure using glucagon receptor antagoni...

Methods for treating obesity and nonalcoholic fatty liver disease o...

Methods for treating type 1 diabetes using glucagon receptor antago...

Patents Applicationslast 30 patents

HUMAN ENDOTHELIN RECEPTOR A (ETAR) ANTAGONIST ANTIBODIES

CHEMOKINE RECEPTOR 4 (CXCR4) ANTAGONIST ANTIBODIES

Methods Of Treating Type 2 Diabetes Mellitus Using Glucagon Recepto...

TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS USING ANTIBODIES...

CANCER TREATMENT USING ANTIBODIES THAT BIND HUMAN CD134 (OX40) RECE...

CALCITONIN GENE-RELATED PEPTIDE (CGRP) ANTAGONIST ANTIBODIES

METHODS FOR TREATING HEART FAILURE USING GLUCAGON RECEPTOR ANTAGONI...

Methods For Treating Obesity And Nonalcoholic Fatty Liver Disease O...

Methods For Treating Type 1 Diabetes Using Glucagon Receptor Antago...

IMMUNOTHERAPY USING ANTIBODIES THAT BIND PROGRAMMED DEATH LIGAND-1...

CANCER TREATMENT USING ANTIBODIES THAT BIND CYTOTOXIC T-LYMPHOCYTE...

IMMUNOTHERAPY USING ANTIBODIES THAT BIND PROGRAMMED DEATH 1 (PD-1)

COMBINATION OF GLUCAGON RECEPTOR ANTAGONISTS AND PI3K PATHWAY INHIB...

Methods For Treating Rare Genetic Disorders Using Glucagon Receptor...

Methods Of Treating Type 2 Diabetes Mellitus Using Glucagon Recepto...

METHODS FOR TREATING HEART FAILURE USING GLUCAGON RECEPTOR ANTAGONI...

Methods For Treating Obesity And Nonalcoholic Fatty Liver Disease O...

Methods For Treating Type 1 Diabetes Using Glucagon Receptor Antago...

Methods For Treating Heart Failure Using Glucagon Receptor Antagonists

Trademarklast 30 trademarks